---
name: Mytos Inc.
slug: mytos
site: cdmo
website_domain: mytos.bio
summary: Automated CDMO for stem-cell derived and regenerative therapies, using its iDEM automated tissue production system to report about 40% lower cost per batch than manual methods. Offers Proof of Value pilots to test technical fit and ROI before scale-up. Headquartered in London, United Kingdom.
tagline: Automated CDMO for regenerative medicines, built on the iDEM automated cell production platform
founded_year: 2016
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: GB
tier2_domain_verified: false
updated_at: 2026-10-20T11:00:54.106Z
services_count: 1
modalities_count: 1
indications_count: 2
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Mytos Inc.

Automated CDMO for regenerative medicines, built on the iDEM automated cell production platform

Listed on cdmo.directory.

## Summary

Automated CDMO for stem-cell derived and regenerative therapies, using its iDEM automated tissue production system to report about 40% lower cost per batch than manual methods. Offers Proof of Value pilots to test technical fit and ROI before scale-up. Headquartered in London, United Kingdom.

## At a glance

- Founded: 2016
- HQ country: GB

## Services

- Cell Therapy Manufacturing

## Modalities

- Cell Therapy

## Indications

- Neurology
- Ophthalmology

## Locations

- London, London, England, United Kingdom

## Long description

## Overview

Mytos describes itself as an automated CDMO for regenerative medicines and a developer of iDEM automated tissue production systems. The company states that therapies work in the clinic but fail to scale because of manual production, and positions its automation as a way to scale in months rather than years.

## Services and technology

- Automated contract manufacturing of stem-cell derived therapies
- iDEM automated cell production technology, described as in its sixth generation of iteration
- Proof of Value pilots: discovery, scoping, and a pilot run in Mytos labs to validate that a client's process can be automated and to demonstrate ROI

## Reported performance

The website cites 4x faster scaling, 10x batches per cleanroom, 40% lower cost per batch, and 10x fewer FTE hours compared with manual production.

## Activity and partners

Mytos reports manufacturing collaborations including Aspen Neuroscience in Parkinson's disease. Other featured partners are Novadip (bone repair), Rinri Therapeutics (hearing), and StemSight (vision). The company is based in London, UK, was founded in 2016, and has raised more than $35 million.

## Related companies

- [Grifols Bio Supplies](/companies/access-biologicals-llc) (Cell Therapy) — [Compare](/compare/access-biologicals-llc/mytos)
- [Enable Biotech Ltd](/companies/enablebiotech) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/enablebiotech/mytos)
- [Kincell Bio](/companies/kincellbio) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/kincellbio/mytos)
- [Celularity](/companies/celularity) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/celularity/mytos)
- [Cell-Easy](/companies/cell-easy) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/cell-easy/mytos)
- [Cellistic](/companies/cellistic) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/cellistic/mytos)
- [Cellares](/companies/cellares) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/cellares/mytos)
- [Made Scientific](/companies/madescientific) (Cell Therapy Manufacturing, Cell Therapy) — [Compare](/compare/madescientific/mytos)

_Profile last updated: 2026-10-20T11:00:54.106Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.